Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020)

Harmony Biosciences Holdings' (HRMY) quarterly Preferred Dividend Payments came in at $6.0 million in Q3 2020, down 33.39% year-on-year from $9.0 million in Q4 2019, and down 42.44% quarter-over-quarter from $10.4 million in Q2 2020.

Harmony Biosciences Holdings (HRMY) Preferred Dividend Payments (2019 - 2020) Analysis & Trends

Harmony Biosciences Holdings has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting $6.0 million for Q3 2020.

  • Preferred Dividend Payments for Q3 2020 came in at $6.0 million, down 33.39% year-over-year; the trailing twelve-month figure through Dec 2020 was $26.9 million (changed N/A YoY), and the FY2020 annual result was $26.9 million, down 23.64% from the prior year.
  • Preferred Dividend Payments came in at $6.0 million for Q3 2020 at Harmony Biosciences Holdings, down from $10.4 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $10.4 million in Q2 2020 to a low of $6.0 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Harmony Biosciences Holdings 1.92 Bn 1.28 Bn 170.88 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 6.01 Mn
Jun 30, 2020 10.45 Mn
Mar 31, 2020 10.45 Mn
Dec 31, 2019 9.58 Mn
Sep 30, 2019 9.03 Mn